Cancer · Austria
Acute myeloid leukemia
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.13 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Intensive chemo, sometimes a stem cell transplant. NHS
We do not have the list of medicines approved in Austria yet. Your doctor knows what is available here.
Being tested in people
13 open trials in Austria, 623 worldwide. See the trials
- 4 chemotherapy blocks: Course 1 AIE (cytarabine/idarubicin/etoposide), Course 2 AI (cytarabine/idarubicin), Course 3 HAD (high-dose cytarabine (1g)/daunorubicin), Course 4 HA (high-dose cytarabine). (Phase 3)
- AG-120 (Phase 3)
- AG-221 (Phase 3)
- all-trans retinoic acid (ATRA) (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
13 open trials in Austria, and 1 opening soon or by invitation
Tests bleximenib with chemotherapy in newly diagnosed acute myeloid leukemia
NCT07223814 · ClinicalTrials.gov
- Linz – Ordensklinikum Linz GmbH
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Age 18 and over
Contact the trial teamTests venetoclax with chemotherapy for newly diagnosed acute myeloid leukemia
NCT04628026 · ClinicalTrials.gov
- Innsbruck – Tirol Kliniken GmbH
- Linz – Kepler Universitaetsklinikum GmbH
- Linz – Ordensklinikum Linz GmbH
- and 3 more sites
Ages 18 to 75
Contact the trial teamTests bleximenib with venetoclax and azacitidine for newly diagnosed acute myeloid leukemia
NCT06852222 · ClinicalTrials.gov
- Linz – Kepler Universitatsklinikum GmbH
- Linz – Ordensklinikum Linz GmbH Elisabethinen
- Salzburg – Universitaetsklinikum Salzburg Landeskrankenhaus
- and 3 more sites
Age 18 and over
Contact the trial teamPivekimab sunirine added to venetoclax and azacitidine for newly diagnosed acute myeloid leukemia
NCT07581002 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Linz – Ordensklinikum Linz GmbH
- Vienna – Medical University of Vienna
- and 1 more site
Age 18 and over
Contact the trial teamTests revumenib with chemotherapy for newly diagnosed acute myeloid leukemia with NPM1 mutation
NCT07211958 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Linz – Ordensklinikum Linz GmbH
- and 1 more site
Age 12 and over
Contact the trial teamTests venetoclax added to ivosidenib and azacitidine for acute myeloid leukemia
2024-512753-24-00 · EU Clinical Trials Register
- Innsbruck – Medizinische Universitaet Innsbruck
- Salzburg – SCRI CCCIT Ges.m.b.H.
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Age 18 and over
Contact the trial teamTests ziftomenib with chemotherapy in children with relapsed acute leukemia
NCT06376162 · ClinicalTrials.gov
- Vienna – St. Anna Kinderspital GmbH
Ages 0 to 21
Contact the trial teamTests bezuclastinib in adults with advanced systemic mastocytosis
NCT04996875 · ClinicalTrials.gov
- Vienna – AKH Wien, Universitatsklinikum
Age 18 and over
Contact the trial teamAdding revumenib to standard treatment for newly diagnosed acute myeloid leukemia
NCT06652438 · ClinicalTrials.gov
- Linz – Kepler Universitaetsklinikum GmbH
- Salzburg – SCRI CCCIT Ges.m.b.H.
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Age 18 and over
Contact the trial teamRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
2025-521390-14-00 · EU Clinical Trials Register
- Vienna – St. Anna Kinderspital GmbH
Up to age 64
Contact the trial teamContinued ASTX727 treatment for people from earlier studies with blood cancers
NCT04093570 · ClinicalTrials.gov
- Vienna – Klinik Hietzing
Age 18 and over
Contact the trial teamTests ivosidenib with azacitidine in adults with a leukemia gene mutation
NCT05907057 · ClinicalTrials.gov
- Linz – Ordensklinikum Linz GmbH
- Vienna – Medical University of Vienna
- Wels – Klinikum Wels-Grieskirchen GmbH
Age 18 and over
Contact the trial teamRegistry study following adults with acute myeloid leukemia and related blood cancers
NCT01252485 · ClinicalTrials.gov
- Graz – Medizinische Universität Graz
- Innsbruck – Medizinische Universität Innsbruck
- Linz – Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.
- and 5 more sites
Age 18 and over
Contact the trial teamAdding venetoclax to standard treatment for IDH1-mutated acute myeloid leukemia
NCT07075016 · ClinicalTrials.gov
- Feldkirch – AT-Feldkirch-IKHF
- Salzburg – AT-Salzburg-SALK
- Vienna – AT-Vienna-HANUSCH
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- ReviewPulmonary embolism as the initial manifestation of acute promyelocytic leukemia: A case report and review of the literature.Medicine (Baltimore) · 2026-10-30
- Not labelled yetNext-Generation Sequencing in Acute Myeloid Leukemia: Advancing Clinical Insights.Anticancer Agents Med Chem · 2026-11-02
- Not labelled yetNeither the pan-immune-inflammation value nor the PILE score improved on APACHE-II or SOFA in a single-center cohort of critically ill older patients with acute myeloid leukemia.Front Med (Lausanne) · 2026-10-27
- Not labelled yetNPM1-mutated AML: One entity, multiple layers of heterogeneity.Br J Haematol · 2026-11-11
- In peopleExpression patterns of hypoxia signaling pathway genes and their association with clinical biochemical parameters in acute myeloid leukemia patients of Assam: A case control study.Mol Biol Rep · 2026-11-11
Not labelled yet: PubMed has not indexed the article yet, so we do not guess.
More research on the disease pageIs it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (7)
- Acute Leukemia Advocates Network (ALAN)
Global network of 69 acute leukaemia patient organisations (hosted by the Swiss Leukemia Patient Advocates Foundation); member list helps patients find a national group.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- European Reference Networks (European Commission)
The European Commission's 24 expert networks for rare and complex diseases; your doctor can contact them.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.